Literature DB >> 8795136

Mechanisms of loss of HLA class I expression on colorectal tumor cells.

M Browning1, F Petronzelli, D Bicknell, P Krausa, A Rowan, S Tonks, N Murray, J Bodmer, W Bodmer.   

Abstract

For several years this laboratory has studied the expression of HLA class I on established colorectal tumor cell lines and on fresh tumors. We review here the mechanisms by which colorectal tumor cells may lose surface expression of HLA class I molecules. Several independent mechanisms have been identified, including loss or mutations in beta 2-microglobulin genes, loss of HLA heavy chain genes, selective lack of expression of HLA alleles, and regulatory defects in HLA expression including loss of expression of the peptide transporters associated with antigen processing (TAP). The data suggest that colorectal tumor cells may evade tumor specific, HLA restricted immune attack by loss of HLA class I expression through a number of mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795136     DOI: 10.1111/j.1399-0039.1996.tb02571.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  14 in total

1.  Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

Authors:  A Hamdi; K Cao; L M Poon; F Aung; S Kornblau; M A Fernandez Vina; R E Champlin; S O Ciurea
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

Review 2.  Targeting T cells with bispecific antibodies for cancer therapy.

Authors:  Lawrence G Lum; Archana Thakur
Journal:  BioDrugs       Date:  2011-12-01       Impact factor: 5.807

Review 3.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  MHC heterogeneity and response of metastases to immunotherapy.

Authors:  Ignacio Algarra; Federico Garrido; Angel M Garcia-Lora
Journal:  Cancer Metastasis Rev       Date:  2021-04-15       Impact factor: 9.264

5.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

6.  Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.

Authors:  Cristina Maccalli; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

7.  False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.

Authors:  Hyewon Park; Jungwon Hyun; Sung Sup Park; Myoung Hee Park; Eun Young Song
Journal:  Korean J Lab Med       Date:  2011-10-03

8.  High-resolution analysis of HLA class I alterations in colorectal cancer.

Authors:  Jan Willem F Dierssen; Noel F C C de Miranda; Arend Mulder; Marjo van Puijenbroek; Willem Verduyn; Frans H J Claas; Cornelis J H van de Velde; Gert Jan Fleuren; Cees J Cornelisse; Willem E Corver; Hans Morreau
Journal:  BMC Cancer       Date:  2006-10-02       Impact factor: 4.430

9.  Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.

Authors:  L A Koopman; W E Corver; A R van der Slik; M J Giphart; G J Fleuren
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

Review 10.  HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Authors:  Per Anderson; Natalia Aptsiauri; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cell Mol Immunol       Date:  2021-01-20       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.